1 hr ago

Concord Biotech Approves 1:1 Bonus Issue; Record Date Pending

Concord Biotech Approves 1:1 Bonus Issue; Record Date Pending
Concord Biotech 1:1 bonus issue: Jhunjhunwala family-backed pharma stock gains 50% in 6 months, check record date detail · livemint.com

Concord Biotech plans to give shareholders one extra share for every share they already own.

This is called a 1:1 bonus issue.

The new shares will have a face value of ₹1 each.

The company has not yet decided the record date.

The record date will determine which shareholders qualify.

The company will also increase the number of shares it is allowed to issue.

Its authorised share capital will double from ₹11 crore to ₹22 crore.

The stock rose nearly 2% after the announcement and has gained about 50% in six months.

Key facts

Bonus ratio
1:1
Bonus entitlement
One ₹1 fully paid-up equity share for every one ₹1 fully paid-up equity share held
Record date
Not yet finalised
Authorised share capital
To increase from ₹11 crore to ₹22 crore
Additional shares created
11 crore shares of ₹1 each
Closing share price
₹1,559.20 on BSE, up 1.87%
Six-month return
Approximately 50.8%

Quotes

Concord Biotech Limited

The Gujarat-headquartered biotech company announcing the bonus-share entitlement in its BSE filing.

“bonus equity share of Re 1 each for every one fully paid-up equity share of Re 1 each.”
livemint.com

Sources

Related news